Capricor Therapeutics Inc (NASDAQ:CAPR)
| 4.57 Delayed Data As of 4:00pm ET |  +0.17 / +3.86%Today’s Change | 3.30 Today|||52-Week Range 6.58 | +18.39% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -12.9M | -18.8M | 2.4M | -15.2M | |
| Depreciation | 110.9K | 125.7K | 144.2K | 157.7K | ||
| Total Other Cash Flow | 1.6M | 3.5M | -13.9M | 1.7M | ||
| Funds From Operations | -11.2M | -15.2M | -11.4M | -13.3M | ||
| Funds From/For Other Operating Expenses | 2.6M | 2.3M | 3.1M | 554.6K | ||
| Net Cash Flow - Operating Activities | -13.8M | -17.6M | -14.5M | -13.9M | ||
| Investing | Increase In Investments | -18.0M | -18.0M | -19.0M | -18.0M | |
| Decrease In Investments | 10.0M | 13.0M | 24.0M | 23.0M | ||
| Capital Expenditures | -151.2K | -193.7K | -32.2K | -316.5K | ||
| Net Cash Flow Investing | -8.1M | -5.2M | 5.0M | 4.7M | ||
| Financing | Short Term Borrowings | 0.00 | 3.1M | 276.3K | 0.00 | |
| Long Term Borrowings | 0.00 | 4.8M | 500.0K | 0.00 | ||
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 16.5M | 13.9M | 11.1M | 6.9M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 16.5M | 21.7M | 11.9M | 6.9M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -5.4M | -1.0M | 2.3M | -2.3M | ||
